Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

A marker for Stevens-Johnson syndrome ...: ethnicity matters.

Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC; RegiSCAR Group.

Pharmacogenomics J. 2006 Jul-Aug;6(4):265-8. Epub 2006 Jan 17.

PMID:
16415921
2.

Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.

Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK.

Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):579-82. doi: 10.4103/0378-6323.57718.

3.

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.

Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P.

Epilepsia. 2010 May;51(5):926-30. doi: 10.1111/j.1528-1167.2010.02533.x. Epub 2010 Mar 19.

4.

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.

Chang CC, Too CL, Murad S, Hussein SH.

Int J Dermatol. 2011 Feb;50(2):221-4. doi: 10.1111/j.1365-4632.2010.04745.x.

PMID:
21244392
5.

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.

Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W.

Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8.

PMID:
19696695
6.

Pharmacogenetics of cutaneous adverse drug reactions.

Aihara M.

J Dermatol. 2011 Mar;38(3):246-54. doi: 10.1111/j.1346-8138.2010.01196.x. Review.

PMID:
21342226
7.

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.

Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M; RegiSCAR study group.

Pharmacogenet Genomics. 2008 Feb;18(2):99-107. doi: 10.1097/FPC.0b013e3282f3ef9c.

PMID:
18192896
8.

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R; JSAR research group.

Epilepsia. 2010 Dec;51(12):2461-5. doi: 10.1111/j.1528-1167.2010.02766.x. Epub 2010 Nov 3.

9.

HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.

Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P.

Pain Pract. 2012 Mar;12(3):202-8. doi: 10.1111/j.1533-2500.2011.00479.x. Epub 2011 Jun 16.

PMID:
21676164
10.

Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.

Zhang Y, Wang J, Zhao LM, Peng W, Shen GQ, Xue L, Zheng XX, He XJ, Gong CY, Miao LY.

Eur J Clin Pharmacol. 2011 Sep;67(9):885-7. doi: 10.1007/s00228-011-1009-4. Epub 2011 Mar 19.

PMID:
21424386
11.

HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.

Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH, Kwan P.

Epilepsia. 2013 Jul;54(7):1307-14. doi: 10.1111/epi.12217. Epub 2013 May 20.

12.

Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT.

Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.

PMID:
20235791
13.

Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?

Shi YW, Min FL, Qin B, Zou X, Liu XR, Gao MM, Wang Q, Zhou JQ, Liao WP.

Basic Clin Pharmacol Toxicol. 2012 Jul;111(1):58-64. doi: 10.1111/j.1742-7843.2012.00868.x. Epub 2012 Mar 17.

14.

Stratification of the risk of serious allergic cutaneous reactions with therapeutic management of trigeminal neuralgia.

Shakib K, Sinanan M.

Br J Oral Maxillofac Surg. 2011 Apr;49(3):235-6. doi: 10.1016/j.bjoms.2010.03.007. Epub 2010 Apr 28.

PMID:
20430493
15.

HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions.

Kano Y, Hirahara K, Asano Y, Shiohara T.

Acta Derm Venereol. 2008;88(6):616-8. doi: 10.2340/00015555-0528. No abstract available.

16.

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V.

Epilepsia. 2008 Dec;49(12):2087-91. doi: 10.1111/j.1528-1167.2008.01719.x. Epub 2008 Jul 14. Erratum in: Epilepsia. 2009 Apr;50(4):971.

17.

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.

Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P, Stefan H, Zhou D.

Epilepsy Behav. 2010 Nov;19(3):405-8. doi: 10.1016/j.yebeh.2010.08.007. Epub 2010 Sep 15.

PMID:
20833111
18.

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY; Taiwan SJS Consortium.

N Engl J Med. 2011 Mar 24;364(12):1126-33. doi: 10.1056/NEJMoa1009717.

19.

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT.

Pharmacogenet Genomics. 2006 Apr;16(4):297-306.

PMID:
16538176
20.

Medical genetics: a marker for Stevens-Johnson syndrome.

Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT.

Nature. 2004 Apr 1;428(6982):486.

PMID:
15057820
Items per page

Supplemental Content

Write to the Help Desk